547 related articles for article (PubMed ID: 15327585)
1. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
DelDot ME; Lipman J; Tett SE
Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Chaijamorn W; Jitsurong A; Wiwattanawongsa K; Wanakamanee U; Dandecha P
Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.
Fuhrmann V; Schenk P; Jaeger W; Ahmed S; Thalhammer F
J Antimicrob Chemother; 2004 Oct; 54(4):780-4. PubMed ID: 15347636
[TBL] [Abstract][Full Text] [Related]
4. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F
J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
[TBL] [Abstract][Full Text] [Related]
7. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
Chadha V; Garg U; Warady BA; Alon US
Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
[TBL] [Abstract][Full Text] [Related]
8. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
9. Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.
Markou N; Fousteri M; Markantonis SL; Zidianakis B; Hroni D; Boutzouka E; Baltopoulos G
J Antimicrob Chemother; 2012 Oct; 67(10):2459-62. PubMed ID: 22790220
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
Fish DN; Teitelbaum I; Abraham E
Antimicrob Agents Chemother; 2005 Jun; 49(6):2421-8. PubMed ID: 15917542
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.
Robatel C; Decosterd LA; Biollaz J; Eckert P; Schaller MD; Buclin T
J Clin Pharmacol; 2003 Dec; 43(12):1329-40. PubMed ID: 14615469
[TBL] [Abstract][Full Text] [Related]
13. Clearance of linezolid via continuous venovenous hemodiafiltration.
Mauro LS; Peloquin CA; Schmude K; Assaly R; Malhotra D
Am J Kidney Dis; 2006 Jun; 47(6):e83-6. PubMed ID: 16731287
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of amphotericin B lipid complex in critically ill patients undergoing continuous venovenous haemodiafiltration.
Malone ME; Corrigan OI; Kavanagh PV; Gowing C; Donnelly M; D'Arcy DM
Int J Antimicrob Agents; 2013 Oct; 42(4):335-42. PubMed ID: 23920093
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
Wallis SC; Mullany DV; Lipman J; Rickard CM; Daley PJ
Intensive Care Med; 2001 Apr; 27(4):665-72. PubMed ID: 11398692
[TBL] [Abstract][Full Text] [Related]
16. An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration.
D'Arcy DM; Casey E; Gowing CM; Donnelly MB; Corrigan OI
BMC Pharmacol Toxicol; 2012 Nov; 13():14. PubMed ID: 23136834
[TBL] [Abstract][Full Text] [Related]
17. Comparison of sustained hemodiafiltration with continuous venovenous hemodiafiltration for the treatment of critically ill patients with acute kidney injury.
Abe M; Okada K; Suzuki M; Nagura C; Ishihara Y; Fujii Y; Ikeda K; Kaizu K; Matsumoto K
Artif Organs; 2010 Apr; 34(4):331-8. PubMed ID: 20420616
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and the most suitable regimen of panipenem/beta mipron in critically ill patients receiving continuous renal replacement therapy: a pilot study.
Hayakawa M; Ito Y; Fujita I; Iseki K; Gando S
ASAIO J; 2006; 52(4):398-403. PubMed ID: 16883119
[TBL] [Abstract][Full Text] [Related]
19. Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration.
Wenisch JM; Meyer B; Fuhrmann V; Saria K; Zuba C; Dittrich P; Thalhammer F
J Antimicrob Chemother; 2012 Apr; 67(4):977-83. PubMed ID: 22210754
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration.
Spooner AM; Deegan C; D'Arcy DM; Gowing CM; Donnelly MB; Corrigan OI
BMC Clin Pharmacol; 2011 Aug; 11():11. PubMed ID: 21816053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]